I use GLP-1s and related drugs in a way that is, without a doubt, a roll of the dice and so far, the odds have been in my favor
Aug 14: In what is expected to become a multibillion-dollar blockbuster, Pfizers BCMAxCD3 bispecific antibody Elrexfio (elranatamab-bcmm) has secured an FDA accelerated approval as another off-the-shelf treatment option for patients with relapsed or refractory multiple myeloma (RRMM) who have received at least four prior lines of therapy
The authors noted that well-designed, adequately powered clinical trials were lacking, and that definitive efficacy claims could not be supported by the existing literature at the time of publication
This mechanism produces more sustained weight loss and metabolic improvement compared to older medication classes, which is why GLP-1 is now considered the standard of care for many patients with obesity or type 2 diabetes
These results have led major medical organizations, including the American Heart Association, to recognize GLP-1 medications as legitimate therapeutic tools for weight management and metabolic health in otherwise healthy populations